Two‐period linear mixed effects models to analyze clinical trials with run‐in data when the primary outcome is continuous: Applications to Alzheimer's disease

Abstract Introduction Study outcomes can be measured repeatedly based on the clinical trial protocol before randomization during what is known as the “run‐in” period. However, it has not been established how best to incorporate run‐in data into the primary analysis of the trial. Methods We proposed...

Full description

Saved in:
Bibliographic Details
Main Authors: Guoqiao Wang, Andrew J. Aschenbrenner, Yan Li, Eric McDade, Lei Liu, Tammie L.S. Benzinger, Randall J. Bateman, John C. Morris, Jason J. Hassenstab, Chengjie Xiong
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Online Access:https://doi.org/10.1016/j.trci.2019.07.007
Tags: Add Tag
No Tags, Be the first to tag this record!